To order: 1-800-565-1975

Book Finder

Use our book finder to discover new and exciting titles!

Choose one or more search parameters in the book finder and click on the Find books button. A list of titles will appear in the main window.

You can then enter more search parameters to narrow your search for the perfect book!

Search by:
Doctors in Denial
look inside

Doctors in Denial

Why Big Pharma and the Canadian medical profession are too close for comfort

By Joel Lexchin, MD, Foreword by Dr. Brian Goldman

This book will be available 1st May 2017. We welcome you to place a pre-order.
$24.95 Paperback
This book will be available 1st May 2017. We welcome you to place a pre-order.
$16.95 Ebook
EPUB Not available

Rating: 0 vote(s).


Doctors in Denial examines the relationship between the Canadian medical profession and the pharmaceutical industry, and explains how doctors have become dependents of the drug companies instead of champions of patients' health. Big Pharma plays a role in every aspect of doctors' work. These giant, wealthy multinationals influence how medical students are trained and receive information, how research is done in hospitals and universities, what is published in leading medical journals, what drugs are approved, and what patients expect when they go into their doctors' offices. But almost all doctors deny the influence and control the drug companies exert. In this book Dr. Lexchin urges the medical profession to make the changes needed to give priority to protecting and promoting patients' health and benefitting society, rather than enabling Big Pharma to dominate health care while raking in billions in profits from citizens and governments.

Tables, Figures and Boxes
Abbreviations
Foreword by Dr. Brian Goldman of CBC Radio's White Coat, Black Art

Introduction: Doctors in denial: welcome to the comfort zone

Chapter 1: Medicine and industry: a marriage of convenience or a marriage made in heaven?

Chapter 2: Government, industry and the medical profession: ménage à trois

Chapter 3: Medical journals— advertisements, money, regulation, rebellion and possibly retrenchment

Chapter 4: Academic health science centres: research, money, controversies, conflict of interest and independence

Chapter 5: Key opinion leaders, clinical practice guidelines and medical societies: getting the message out

Chapter 6: Guidelines on relationships between industry and the medical profession: a guide to salvation?

Chapter 7: Medical students and physicians-in-training (residents): get them while they are young

Chapter 8: Doctors, sales representatives, samples, gifts, trips and dinners

Chapter 9: Don't worry, be happy?

Chapter 10: Reforming the comfort zone so that doctors are no longer in denial

Acknowledgements
References
Index

Joel Lexchin is an internationally-recognized expert in pharmaceutical policy. He received his MD from the University of Toronto in 1977 and has spent over thirty years working as an emergency physician in Hamilton and Toronto. He is a Professor Emeritus in the School of Health Policy and Management at York University where he taught health policy from 2001 to 2016. He has been an advocate for change in pharmaceutical policy for thirty-five years, has appeared before numerous parliamentary committees, and has authored or co-authored over 150 articles about all aspects of how medicines are developed and used. His most recent book Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State was published in early 2016.

Customer Reviews:

Your review
Rating:



Publication Details:

Binding: Paperback, 334 pages
Publication Date: 1st May 2017
ISBN: 9781459412446
Format: 9in x 6in
10+ tables, graphs, charts

Binding: Electronic book text, 344 pages
Publication Date: 1st May 2017
ISBN: 9781459412453
Format: EPUB
10+ tables, graphs, charts

BISAC Code:  MED036000, MED039000, MED072000, MED104000
Imprint: Lorimer


back

Bookmark and Share

Currencies

Our books are priced in Canadian dollars.